|
1
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by Beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang XH, Yu J, Brown K and Levine B:
Beclin 1 contains a leucine-rich nuclear export signal that is
required for its autophagy and tumor suppressor function. Cancer
Res. 61:3443–3449. 2001.PubMed/NCBI
|
|
3
|
Kang R, Livesey KM, Zeh HJ, Loze MT and
Tang D: HMGB1: A novel Beclin 1-binding protein active in
autophagy. Autophagy. 6:1209–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang R, Zeh HJ, Lotze MT and Tang D: The
Beclin 1 network regulates autophagy and apoptosis. Cell Death
Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abrahamsen H, Stenmark H and Platta HW:
Ubiquitination and phosphorylation of Beclin 1 and its binding
partners: Tuning class III phosphatidylinositol 3-kinase activity
and tumor suppression. FEBS Lett. 586:1584–1591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang ZH, Xu L, Duan ZL, Zeng LQ, Yan NH
and Peng ZL: Beclin 1-mediated macroautophagy involves regulation
of caspase-9 expression in cervical cancer HeLa cells. Gynecol
Oncol. 107:107–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li H, Wang P, Sun Q, Ding WX, Yin XM,
Sobol RW, Stolz DB, Yu J and Zhang L: Following cytochrome c
release, autophagy is inhibited during chemotherapy-induced
apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res.
71:3625–3634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu Y, Zhao L, Liu L, Gao P, Tian W, Wang
X, Jin H, Xu H and Chen Q: Beclin 1 cleavage by caspase-3
inactivates autophagy and promotes apoptosis. Protein Cell.
1:468–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong C, Bauvy C, Tonelli G, Yue W,
Deloménie C, Nicolas V, Zhu Y, Domergue V, Marin-Esteban V,
Tharinger H, et al: Beclin 1 and autophagy are required for the
tumorigenicity of breast cancer stem-like/progenitor cells.
Oncogene. 32:2261–2272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the Beclin
1 autophagy gene. J Clin Invest. 112:1809–1820. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan
DS, Zhu XF and Zhang XS: The expression of beclin 1 is associated
with favorable prognosis in stage IIIB colon cancers. Autophagy.
5:303–306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park JM, Huang S, Wu TT, Foster NR and
Sinicrope FA: Prognostic impact of Beclin 1, p62/sequestosome 1 and
LC3 protein expression in colon carcinomas from patients receiving
5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther.
14:100–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koneri K, Goi T, Hirono Y, Katayama K and
Yamaguchi A: Beclin 1 gene inhibits tumor growth in colon cancer
cell lines. Anticancer Res. 27:1453–1457. 2007.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Lu Y, Lu C and Zhang L: Beclin-1
expression is a predictor of clinical outcome in patients with
esophageal squamous cell carcinoma and correlated to
hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res.
15:487–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong LW, Hou YJ, Tan YX, Tang L, Pan YF,
Wang M and Wang HY: Prognostic significance of Beclin 1 in
intrahepatic cholangiocellular carcinoma. Autophagy. 7:1222–1229.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duan ZL, Peng ZL and Wang ZH: Expression
and involved signal transduction pathway of autophagy gene Beclin
1in epithelial ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban.
38:239–242. 2007.(In Chinese). PubMed/NCBI
|
|
19
|
Huang X, Bai HM, Chen L, Li B and Lu YC:
Reduced expression of LC3B-II and Beclin 1 in glioblastoma
multiforme indicates a down-regulated autophagic capacity that
relates to the progression of astrocytic tumors. J Clin Neurosci.
17:1515–1519. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang ZF, Shao LJ, Wang WM, Yan XB and Liu
RY: Decreased expression of Beclin-1 and LC3 in human lung cancer.
Mol Biol Rep. 39:259–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pirtoli L, Cevenini G, Tini P, Vannini M,
Oliveri G, Marsili S, Mourmouras V, Rubino G and Miracco C: The
prognostic role of Beclin 1 protein expression in high-grade
gliomas. Autophagy. 5:930–936. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi YH, Ding ZB, Zhou J, Qiu SJ and Fan J:
Prognostic significance of Beclin 1-dependent apoptotic activity in
hepatocellular carcinoma. Autophagy. 5:380–382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wan XB, Fan XJ, Chen MY, Xiang J, Huang
PY, Guo L, Wu XY, Xu J, Long ZJ, Zhao Y, et al: Elevated Beclin 1
expression is correlated with HIF-1alpha in predicting poor
prognosis of nasopharyngeal carcinoma. Autophagy. 6:395–404. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang ZH, Peng ZL, Duan ZL and Liu H:
Expression and clinical significance of autophagy gene Beclin 1 in
cervical squamous cell carcinoma. Sichuan Da Xue Xue Bao Yi Xue
Ban. 37:860–863. 2006.(In Chinese). PubMed/NCBI
|
|
25
|
Won KY, Kim GY, Lim SJ and Kim YW:
Decreased Beclin-1 expression is correlated with the growth of the
primary tumor in patients with squamous cell carcinoma and
adenocarcinoma of the lung. Hum Pathol. 43:62–68. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pajalunga D, Mazzola A, Franchitto A,
Puggioni E and Crescenzi M: The logic and regulation of cell cycle
exit and reentry. Cell Mol Life Sci. 65:8–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Müller GA and Engeland K: The central role
of CDE/CHR promoter elements in the regulation of cell
cycle-dependent gene transcription. FEBS J. 277:877–893. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang C, Lisanti MP and Liao DJ: Reviewing
once more the c-myc and Ras collaboration: Converging at the cyclin
D1-CDK4 complex and challenging basic concepts of cancer biology.
Cell Cycle. 10:57–67. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang LH, Song YB, Zheng WL, Jiang L and Ma
WL: The association between polymorphisms in the MDR1 gene and risk
of cancer: A systematic review and pooled analysis of 52
case-control studies. Cancer Cell Int. 13:462013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng HC, Takahashi H, Li XH, Hara T,
Masuda S, Guan YF and Takano Y: Overexpression of GRP78 and GRP94
are markers for aggressive behavior and poor prognosis in gastric
carcinomas. Hum Pathol. 39:1042–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ninomiya-Tsuji J, Kishimoto K, Hiyama A,
Inoue J, Cao Z and Matsumoto K: The kinase TAK1 can activate the
NIK-I kappaB as well as the MAP kinase cascade in the IL-1
signaling pathway. Nature. 398:252–256. 1999. View Article : Google Scholar : PubMed/NCBI
|
